enoximone has been researched along with Chronic Disease in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (54.55) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, WT; Böhm, M; Bristow, MR; Corbalan, R; De Marco, T; DeMets, D; Eichhorn, E; Elkayam, U; Gerber, M; Komajda, M; Linseman, J; Liu, P; Mareev, V; Metra, M; Perrone, SV; Poole-Wilson, P; Roecker, E; Stewart, J; Swedberg, K; Tendera, M; Wiens, B | 1 |
| Bristow, MR; D'Aloia, A; Dei Cas, L; Metra, M; Muneretto, C; Nodari, S; Robertson, AD | 1 |
| Campana, C; Constantin, C; Fontana, A; Ghio, S; Klersy, C; Raineri, C; Tavazzi, L | 1 |
| Francis, GS; Tang, WH | 1 |
| Botvinick, EH; Buckingham, M; Chatterjee, K; Kereiakes, DJ; Lanzer, P; Parmley, WW; Spangenberg, R; Viquerat, C | 1 |
| Amin, DK; Hulse, S; Shah, PK; Shellock, FG; Swan, HJ | 1 |
| Dubrey, SW; Gnanasakthy, A; Hardman, T; Hynd, J; Noble, MI; Song, JG; Stein, WK | 1 |
| Barbato, G; Bracchetti, D; Cantelli, I; Casella, G; Pavesi, PC | 1 |
| Annane, D; Bellissant, E; Depret, J; Richard, C; Teboul, JL; Thuillez, C | 1 |
| Swan, HJ | 1 |
| Bounhoure, JP; Edouard, P; Fauvel, JM; Fourcade, J; Galinier, M; Massabuau, P; Puel, J; Rochiccioli, JP | 1 |
| Garraffo, R; Gibelin, P; Lapalus, P; Morand, P; Sbirrazzuoli, V | 1 |
| Dieterich, HA; Fehske, W; Peters, P; Saborowski, F; Schneider, M | 1 |
| Gilfrich, HJ; Römer, A; Witzke-Gross, J | 1 |
| Erbel, R; Meyer, J; Rhein, S; Treese, N | 1 |
| Janicki, JS; Maskin, CS; Weber, KT | 2 |
| Janicki, JS; Shroff, SG; Weber, KT | 1 |
| Crawford, MH | 1 |
| Helfer, D; Jessup, M; Samaha, J; Ulrich, S | 1 |
| Choraria, S; Dieterich, HA; Erbel, R; Meyer, J; Pilcher, J; Rhein, S; Treese, N | 1 |
| Amin, DK; Hulse, S; Shah, PK; Shellock, F | 1 |
2 review(s) available for enoximone and Chronic Disease
| Article | Year |
|---|---|
The year in heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Pacing, Artificial; Cardiography, Impedance; Cardiomyopathy, Dilated; Chronic Disease; Clinical Trials as Topic; Comorbidity; Disease Management; Enoximone; Heart Failure; Hemodynamics; Humans; Kidney Diseases; Natriuretic Peptide, Brain; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase; Pacemaker, Artificial; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Xanthine Oxidase | 2005 |
Effects of new inotropic agents on exercise performance.
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Chronic Disease; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Muscles; Oxygen; Oxygen Consumption; Physical Exertion; Pulmonary Wedge Pressure; Pyridones; Time Factors | 1986 |
9 trial(s) available for enoximone and Chronic Disease
| Article | Year |
|---|---|
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiotonic Agents; Chronic Disease; Double-Blind Method; Enoximone; Exercise; Exercise Tolerance; Heart Failure; Heart Rate; Hospitalization; Humans; Kaplan-Meier Estimate; Middle Aged; Young Adult | 2009 |
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Angiography; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Chronic Disease; Dobutamine; Echocardiography; Enoximone; Exercise Test; Female; Heart Failure; Humans; Image Enhancement; Male; Middle Aged; Myocardial Infarction; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Enoximone in chronic stable angina: a double-blind placebo-controlled cross-over trial.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Double-Blind Method; Electrocardiography; Enoximone; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia | 1994 |
Comparative hemodynamic effects of intravenous digoxin and enoximone in severe chronic heart failure.
Topics: Adult; Aged; Chronic Disease; Coronary Disease; Cross-Over Studies; Digoxin; Enoximone; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Severity of Illness Index; Ventricular Function, Left | 1994 |
[Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Topics: Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged | 1990 |
[Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
Topics: Aged; Cardiotonic Agents; Chronic Disease; Drug Evaluation; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Injections, Jet; Middle Aged | 1990 |
Intravenous use of enoximone.
Topics: Adolescent; Adult; Aged; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Enoximone; Female; Heart Failure; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged | 1987 |
Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience.
Topics: Adult; Capsules; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Echocardiography; Enoximone; Exercise Test; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Long-Term Care; Middle Aged | 1987 |
11 other study(ies) available for enoximone and Chronic Disease
| Article | Year |
|---|---|
Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.
Topics: Aged; Blood Pressure; Cardiac Volume; Cardiotonic Agents; Chronic Disease; Enoximone; Female; Heart Failure; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged; Mitral Valve Insufficiency; Myocardial Contraction; Pulmonary Wedge Pressure; Vascular Resistance; Vasodilator Agents | 1984 |
Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure.
Topics: Aged; Blood Flow Velocity; Cardiotonic Agents; Chronic Disease; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Lactates; Lactic Acid; Male; Middle Aged; Myocardium; Oxygen Consumption | 1984 |
Effects of cardiovascular drugs on oxygen consumption/oxygen delivery relationship in patients with congestive heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Catheterization, Swan-Ganz; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Edema | 1992 |
Enoximone in chronic heart failure.
Topics: Cardiotonic Agents; Chronic Disease; Enoximone; Heart Failure; Humans; Imidazoles; Phosphodiesterase Inhibitors; Survival Analysis | 1990 |
Acute effects of enoximone in chronic heart failure.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged | 1989 |
Chronic therapy of severe heart failure with enoximone.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged | 1989 |
Long-term enoximone therapy in unstable chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Chronic Disease; Electrocardiography; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged | 1989 |
Physiologic response to the inotropic and vasodilator properties of enoximone.
Topics: Animals; Cardiotonic Agents; Chronic Disease; Coronary Vessels; Dogs; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Models, Cardiovascular; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardium; Oxygen Consumption; Vasodilation | 1987 |
Long-term oral enoximone therapy in chronic cardiac failure.
Topics: Administration, Oral; Adult; Aged; Cardiotonic Agents; Chronic Disease; Drug Evaluation; Enoximone; Exercise Test; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Long-Term Care; Male; Middle Aged | 1987 |
Effects of low dose enoximone for chronic congestive heart failure.
Topics: Administration, Oral; Aged; Cardiotonic Agents; Chronic Disease; Drug Evaluation; Enoximone; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged | 1987 |
Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Enoximone; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside; Time Factors; Vasodilator Agents | 1985 |